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were found to result in a variability below 5% in parameters measured di-
rectly from the average waveform, and up to 10% in those obtained from
the time derivative. Subsequently, the feasibility of an automated version of
the algorithm, based on objective operator independent criteria, was evalu-
ated, and parameters obtained were found to be in excellent agreement with
those obtained using manual approach. In summary, this algorithm provides
a fast. easy and objective method for noise reduction in acoustic quantifica-
tion signals. This algorithm may improve the on-line noninvasive assessment
of systolic and diastolic LV function.
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Congenital heart disease (CHD) is the most common congenital malforma-
tion with an incidence rate of 0.7%. Many pregnant woman (in some coun-
tries all) are offered an ultrasound scan at around 18 weeks of pregnancy.
The scan incorporates a detailed anatomical survey of the fetus and if in-
cludes at least a four chamber view, it is an excellent opportunity to detect
congenital heart defects. Therefore a Windows based multimedia computer
program for the instruction of Fetal Echo for ultrasound technologists, stu-
dents. residents, fellows and primary care physicians has been developed.
The application includes a step by step tutorial to instruct the user in reading
Fetal Echo data, a browsing library of definitions of CHD's, graphics images
and digitized echocardiograms, and the Expert System for automatic diagno-
sis. The pictures, images and descriptions are linked to a database and can
be viewed by searching for the defect name or symptoms. This provides a
powerful instructional tool in this very difficult area of medical education.
The minimum hardware requirements to run this program are: IBMIPC or
compatible computer running MS Windows version 3.1 with 80386SX pro-
cessor,4 MB RAM, 30 MB free disk space, multimedia with dual speed CD
ROM, and a VGA card capable to display at least 256 colors.
Steven Georgeson. Somerset Medical Center, Somerville, NJ
The differentiation between atrioventricular reciprocating tachycardia via an
accessory pathway (AVRT). AV nodal reentrant tachycardia (AVNRT) and atrial
tachycardia (AT) in paroxysmal supraventricular tachycardia may be helpful
in guiding pharmacologic therapy and in identifying patients for radiofre-
quency catheter ablation. To help in this differentiation, an expert system
was developed using a commercially-available expert system shell (EXSl'S).
A simplified version of this system was designed to run on a palm-top com-
puter. Both programs use the MS-DOS operating system. The expert system
is rule-based and assigns probability values to the goal states through the
process of backward chaining. The goal states for this expert system were
AVRT, AVNRT, and AT. The user is queried for the presence of various abnor-
malities on the presenting EKG (P wave location, ORS alternans, pseudo r
wave in lead V1, pseudo S wave in the inferior leads), comparison with pre-
vious EKG's (presence of pre-excitation) and the effect of vagal manueuvers
or adenosine infusion on the tachycardia. From published data, each abnor-
mality is assigned a probability based on the positive predictive value of the
abnormality for AVRT, AVNRT and AT. By combining the positive predictive
values, the expert system assigns a final probability for AVRT, AVNRT and AT.
This expert system may be useful as a diagnostic tool and a teaching aid
in the differentiation between AVRT, AVNRT and AT in paroxysmal supraven-
tricular tachycardia.
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Full Antiplatelet Therapy without Anticoagulation
After Coronary Stenting
The purpose of the Benestent II Pilot Phase was to explore the safety of
reducing antithrombotic therapy in conjunction with implantation of heparin-
coated stents. The study consists of three phases, where resumption of hep-
arin therapy after stent implantation was progressively delayed in a stepped
care approach.
Material and Methods. Palmaz-Schatz stents with heparin coating were
implanted in 51 patients (88% male) with stable angina pectoris. Heparin
treatment was withheld 6 hours following removal of the sheath introducer
from the femoral artery. The mean age was 59 years, 10% had a previous
myocardial infarction, diabetes was prevalent in 8%, hypertension in 24%
and 59% were current or previous smokers. Target lesion was located in
the left anterior descending artery in 51 %, left circumflex in 8% and right
coronary artery in 41 %. TIM I flow I-II was present in 14% and TIMIIlI in 86%.
The mean pre-procedural minimal lumen diameter (MLD) was 1.10 mm and
reference diameter 3.16 mm.
Results. Stent implantation was successful in all patients and following the
procedure, mean MLD increased to 2.77 mm and percent diameter stenosis
was reduced from 65% to 19%. The maximum balloon size was 3.45 ± 0.40
mm. Post-stent dilatation was performed in 40 patients (80%). High pressure
(> 12 atm) was used in 22 of these cases (54%). Two patients needed a sec-
ond stent· one for an occlusive distal dissection and one for a distal lesion.
There we;e no major complications, i.e. death, myocardial infarction, urgent
CABG, re-PTCA or cerebrovascular accident. Peripheral vascular complica-
tions required vascular surgery in 3 patients (5.9%) and blood transfusion in
one (2%).
Conclusions. In this pilot study implantation of heparinized stents was as-
sociated with a 100% success rate, absence of serious complications and
a moderate incidence of vascular complications. Further reduction of an-
tithrombotic treatment may be feasible.
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Subacute thrombosis remains a major limitation of coronary stenting. In addi-
tion, local complications related to the intensive anticoagulation that is com-
monly employed are frequent.
We prospectively studied a regime of intensive antiplatelet therapy (as-
pirin 200 mg daily begun before percutaneous transluminal coronary angio-
plasty, ticlodipine 500 mg daily for 3 months begun just after angioplasty)
with periprocedural dextran infusion continued for a period at the discretion
of the local investigator. To date, 98 patients (85 men, 13 women) undergo-
ing 102 procedures involving 125 stents have been enrolled; 71 patients had
one stent implanted; 19 patients had 2 stents implanted, and 2 patients had
3 stents implanted. Symptoms before coronary angioplasty included effort
angina (23%), angina at rest (6%), unstable angina (23%), recent myocardial
infarction (27%). The indications for stent implantation were occlusive dis-
section 36%, dissection without occlusion 32%, suboptimal result or elec-
tive implantation 32%. The stented site was the LAD (37%). RCA (35%). LCx
(17%), and vein graft (11 %). Stent types were Wiktor (70%), Palmaz-Schatz
(23%). Gianturco-Roubin (7%). The diameter of the stents implanted was 2.5
mm (2%), 3.0 mm (32%), 3.5 mm (44%), and 4.0 mm (22%). There were 2
deaths; 1 patient died from cardiogenic shock that was present before stent
implantation 1 patient commited suicide; 4 patients developed q-wave AMI,
1 was already complete at the time of stent implant. 3 occurred In the hours
after stent implant for occlusive dissection; 8 patients had non-O AMI; 3 pa-
tients had CABG, 1 at 5 hours post stent for reocclusion (non-O wave AMI).
2 were performed electively without sequelae for an unsatisfactory angio-
graphic result but without ongoing ischemia. Blood transfusion for peripro-
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